Feed/Investors/Sherpa Healthcare Partners

Sherpa Healthcare Partners

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on 3 rounds in the feed, most often at Series A and in Biotech.

Rounds from 2025-12-15 to 2026-10-13

ROUNDS

led 1, joined 2

LED ROUNDS · USD

$44.8M

across 1 round

LATEST ROUND

Series A · $44.8M · 2026-10-13

CO-INVESTORS

named beside it

Rounds

[ 3 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Allygen Biologics Innovative biotechnology, targeted conjugate drugs	Series A Verified against 3 sources	$44.8M	2026-10-13	[ LEAD ]
Link Cell Therapies An oncology cell therapy company utilizing its proprietary logic-gating technology to develop next-generation CAR-T therapeutics for solid tumors and hematologic malignancies	Series A Verified against 4 of 6 sources	$30M	2026-09-28	[ PART ]
Link Cell Therapies An oncology cell therapy company utilizing its proprietary logic-gating technology to develop next-generation CAR-T therapeutics for solid tumors and hematologic malignancies	Series A Verified against 1 of 4 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$60M	2025-12-15	[ PART ]